Clinical Trial Update: Effectiveness of Nucleoside Supplementation or Switch to Tenofovir in Reversing Fat Loss in HIV Infected Adults [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating nucleoside supplementation or switching to tenofovir to reverse fat loss in HIV-infected adults with lipodystrophy; results have been p…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• HIV Infection
• Lipodystrophy

Drugs mentioned

• Viread (tenofovir disoproxil fumarate)

Snippet

Sponsor: National Institute of Allergy and Infectious Diseases (NIAID) | Conditions: HIV Infections, Lipodystrophy | Phase 2 | Status: COMPLETED | Results posted: 2017-05-12